Nuclear PXN enhanced tumor angiogenesis by increasing tPA expression, resulting in LRP1-mediated NF-κB activation, a process involving the nonreceptor tyrosine kinase protein SRC [21]. This evidence concerns the gene LRP1 and neoplasm.